2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Lymphoma, B-Cell
19
Lymphoma, Large B-Cell, Diffuse
18
Recurrence
13
Lymphoma, Non-Hodgkin
13
Multiple Myeloma
12
Burkitt Lymphoma
11
Lymphoma, Mantle-Cell
8
Lymphoma
8
Leukemia, Myeloid, Acute
8
Carcinoma, Hepatocellular
7
Pancreatic Neoplasms
6
Neoplasms
6
Lymphoma, Follicular
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Leukemia
5
Glioma
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Leukemia, B-Cell
4
Hematologic Neoplasms
4
Neoplasm, Residual
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Esophageal Neoplasms
3
Breast Neoplasms
3
Simpson-Golabi-Behmel syndrome
2
Sarcoma, Synovial
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Interventions
Cyclophosphamide
101
Etoposide
60
Carboplatin
55
Vincristine
51
Filgrastim
49
Topotecan
44
Temozolomide
44
Melphalan
44
Isotretinoin
44
Doxorubicin
44
Irinotecan
42
Cisplatin
35
3-Iodobenzylguanidine
34
Peripheral Blood Stem Cell Transplantation
31
dinutuximab
30
Granulocyte Colony-Stimulating Factor
30
Radiotherapy
29
sargramostim
28
Granulocyte-Macrophage Colony-Stimulating Factor
25
Busulfan
22
Magnetic Resonance Spectroscopy
19
aldesleukin
18
Thiotepa
18
fludarabine
17
Interleukin-2
17
humanized 3F8 anti-GD2 monoclonal antibody
16
etoposide phosphate
16
naxitamab
15
Ifosfamide
15
Biopsy
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Immunotherapy, Adoptive
×
Clear all
NCT02100891
2025-03-19
STIR
Medical College of Wisconsin
Phase 2
Terminated
15 enrolled
11 charts